Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Are cannabinoid receptor knockout mice animal models for schizophrenia?

Medical hypotheses - 1 Jun 2001

Fritzsche M

Abstract excerpt

Schizophrenia is a devastating psychiatric disorder with a high prevalence worldwide. There is therefore a need for animal models allowing the development of new therapeutic interventions and reliable diagnostic tests. In the temporal domain, cannabinoid receptor gene (CB1) knockout mice exhibit...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Disease Models, Animal
Share to DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, Knockout

Share to Phenotype

Share to Receptors, Drug

Share to Schizophrenia

Source

Identifiers

PMID: 11399112
DOI: 10.1054/mehy.2000.1261

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11399112-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Are cannabinoid receptor knockout mice animal models for schizophrenia?PMID 11399112Read ↗

Delayed onset of huntington′s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptorsSemantic proximity Read ↗

CRISPR/Cas9 as a Simple Technique for the Generation of Murine Knockout Models for Neuropsychiatric Diseases.Semantic proximity Read ↗

Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of Psychosis.Semantic proximity Read ↗

Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic miceSemantic proximity Read ↗

Cannabidiol-Induced Recovery of Social Behaviour in Mouse Models of Syndromic AutismSemantic proximity Read ↗

Cannabinoids and psychosis.Semantic proximity Read ↗

Long-term decreased cannabinoid type-1 receptor activity restores specific neurological phenotypes in the Ts65Dn mouse model of Down syndromeSemantic proximity Read ↗

Cannabidiol (CBD) does not reduce cocaine reward or self-administration in a mouse model of schizophrenia genetic susceptibility.Semantic proximity Read ↗

Role of cannabis and endocannabinoids in the genesis of schizophrenia.Semantic proximity Read ↗

Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disordersSemantic proximity Read ↗

Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice.Semantic proximity Read ↗

Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.